• Research & Development

  New Drug Application for Trevyent

  Posted by Colleen on September 13, 2019 at 8:00 am

  The United Therapeutics Corp. has made an exciting announcement that the new drug application for Trevyent, a treatment that uses treprostinil, has been accepted by the Food and Drug Administration. Now it is under review by the FDA and putting us a step closer to a new treatment for PH patients.

  Here are two article explaining this new treatment and how it will be administered. Let’s us know your thoughts about this hope for the near future.

  First article…

  https://www.bizjournals.com/washington/news/2019/09/11/united-therapeutics-advances-new-pulmonary.html

  And….

  https://www.team-consulting.com/work/patchpump-platform-technology/

  replied 4 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply